183 related articles for article (PubMed ID: 23802592)
41. The effect of dexmedetomidine on arterial-cardiac baroreflex function assessed by spectral and transfer function analysis.
Ehara T; Ogawa Y; Kato J; Aoki K; Ogawa S; Iwasaki K
J Anesth; 2012 Aug; 26(4):483-9. PubMed ID: 22382664
[TBL] [Abstract][Full Text] [Related]
42. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow.
Prielipp RC; Wall MH; Tobin JR; Groban L; Cannon MA; Fahey FH; Gage HD; Stump DA; James RL; Bennett J; Butterworth J
Anesth Analg; 2002 Oct; 95(4):1052-9, table of contents. PubMed ID: 12351293
[TBL] [Abstract][Full Text] [Related]
43. Effects of MK-467 on the antinociceptive and sedative actions and pharmacokinetics of medetomidine in dogs.
Bennett RC; Salla KM; Raekallio MR; Hänninen L; Rinne VM; Scheinin M; Vainio OM
J Vet Pharmacol Ther; 2016 Aug; 39(4):336-43. PubMed ID: 26763145
[TBL] [Abstract][Full Text] [Related]
44. Sedative effect of intramuscular medetomidine with and without vatinoxan (MK-467), and its reversal with atipamezole in sheep.
Adam M; Raekallio MR; Vainio OM
Vet Anaesth Analg; 2018 Nov; 45(6):788-793. PubMed ID: 30301665
[TBL] [Abstract][Full Text] [Related]
45. Dexmedetomidine prevents alterations of intestinal microcirculation that are induced by surgical stress and pain in a novel rat model.
Yeh YC; Sun WZ; Ko WJ; Chan WS; Fan SZ; Tsai JC; Lin TY
Anesth Analg; 2012 Jul; 115(1):46-53. PubMed ID: 22504209
[TBL] [Abstract][Full Text] [Related]
46. Dexmedetomidine decreases the oral mucosal blood flow.
Kawaai H; Yoshida K; Tanaka E; Togami K; Tada H; Ganzberg S; Yamazaki S
Br J Oral Maxillofac Surg; 2013 Dec; 51(8):928-31. PubMed ID: 23958351
[TBL] [Abstract][Full Text] [Related]
47. Effects of dexmedetomidine combined with commonly administered opioids on clinical variables in dogs.
Nishimura LT; Auckburally A; Santilli J; Vieira BHB; Garcia DO; Honsho CS; de Mattos-Junior E
Am J Vet Res; 2018 Mar; 79(3):267-275. PubMed ID: 29466048
[TBL] [Abstract][Full Text] [Related]
48. Dual alpha(2)-adrenergic agonist and alpha(1)-adrenergic antagonist actions of dexmedetomidine on human isolated endothelium-denuded gastroepiploic arteries.
Hamasaki J; Tsuneyoshi I; Katai R; Hidaka T; Boyle WA; Kanmura Y
Anesth Analg; 2002 Jun; 94(6):1434-40, table of contents. PubMed ID: 12032002
[TBL] [Abstract][Full Text] [Related]
49. Intranasal dexmedetomidine in healthy beagles: An echocardiographic and pharmacokinetic/pharmacodynamic study.
Santangelo B; Harel M; Fourel I; Micieli F; Cataldi M; Segard-Weisse E; Portier K
Vet J; 2019 Sep; 251():105346. PubMed ID: 31492384
[TBL] [Abstract][Full Text] [Related]
50. Organ-Protective Effects and the Underlying Mechanism of Dexmedetomidine.
Bao N; Tang B
Mediators Inflamm; 2020; 2020():6136105. PubMed ID: 32454792
[TBL] [Abstract][Full Text] [Related]
51. Hemodynamic and anesthetic advantages of dexmedetomidine, an alpha 2-agonist, for surgery in prone position.
Ozkose Z; Demir FS; Pampal K; Yardim S
Tohoku J Exp Med; 2006 Oct; 210(2):153-60. PubMed ID: 17023769
[TBL] [Abstract][Full Text] [Related]
52. Effects of acepromazine or dexmedetomidine on fentanyl disposition in dogs during recovery from isoflurane anesthesia.
Keating S; Kerr C; McDonell W; Valverde A; Johnson R; Knych H; Edginton A
Vet Anaesth Analg; 2016 Jan; 43(1):35-43. PubMed ID: 25943714
[TBL] [Abstract][Full Text] [Related]
53. The sedative effects and the attenuation of cardiovascular and arousal responses during anesthesia induction and intubation in pediatric patients: a randomized comparison between two different doses of preoperative intranasal dexmedetomidine.
Wang SS; Zhang MZ; Sun Y; Wu C; Xu WY; Bai J; Cai MH; Lin L
Paediatr Anaesth; 2014 Mar; 24(3):275-81. PubMed ID: 24224515
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the effects of dexmedetomidine administered at two different times on renal ischemia/reperfusion injury in rats.
Gonullu E; Ozkardesler S; Kume T; Duru LS; Akan M; Guneli ME; Ergur BU; Meseri R; Dora O
Braz J Anesthesiol; 2014; 64(3):152-8. PubMed ID: 24907872
[TBL] [Abstract][Full Text] [Related]
55. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
[TBL] [Abstract][Full Text] [Related]
56. Use of quantitative contrast-enhanced ultrasonography to detect diffuse renal changes in Beagles with iatrogenic hypercortisolism.
Haers H; Daminet S; Smets PM; Duchateau L; Aresu L; Saunders JH
Am J Vet Res; 2013 Jan; 74(1):70-7. PubMed ID: 23270348
[TBL] [Abstract][Full Text] [Related]
57. Sedative and cardiovascular effects of intranasal or intramuscular dexmedetomidine in healthy dogs.
Micieli F; Santangelo B; Reynaud F; Mirra A; Napoleone G; Della Valle G; Portier KG; Vesce G
Vet Anaesth Analg; 2017 Jul; 44(4):703-709. PubMed ID: 28716686
[TBL] [Abstract][Full Text] [Related]
58. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
59. Randomised controlled trial of dexmedetomidine sedation vs general anaesthesia for inguinal hernia surgery on perioperative outcomes in infants.
Bong CL; Tan J; Lim S; Low Y; Sim SW; Rajadurai VS; Khoo PC; Allen J; Meaney M; Koh WP
Br J Anaesth; 2019 May; 122(5):662-670. PubMed ID: 30916007
[TBL] [Abstract][Full Text] [Related]
60. The effect of dexmedetomidine on nutrient organ blood flow.
Lawrence CJ; Prinzen FW; de Lange S
Anesth Analg; 1996 Dec; 83(6):1160-5. PubMed ID: 8942579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
